Active Shortage

APO-MIRABEGRON

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-MIRABEGRON in Canada?

Yes. APO-MIRABEGRON 50MG has an active shortage reported to Health Canada (last updated June 25, 2026).

Why is APO-MIRABEGRON not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-MIRABEGRON be available again?

The estimated resolution date (July 3, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file3 products

Affected strength50MG

Last updated2026-06-25

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

MYRBETRIQ

ASTELLAS PHARMA CANADA INC

50MG · DIN 02402882

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

AURO-MIRABEGRON

AURO PHARMA INC

50MG · DIN 02564955

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

SANDOZ MIRABEGRON

SANDOZ CANADA INCORPORATED

50MG · DIN 02558483

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2026-07-03

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02564971

Strength

50MG

Dosage Form

TABLET (EXTENDED-RELEASE)

Route

ORAL

Active Ingredient

MIRABEGRON

Tier

Unrated

Last Updated

2026-06-25

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244